All lobbying filings

Steptoe LLP

Steptoe LLP filed a Q2 report for Orexo US, Inc. on July 20, 2026, reporting $150,000 in lobbying income.

Lobbying for Orexo US, Inc. · Pharmaceuticals / health products

As filed: STEPTOE LLP for OREXO US, INC.

All filings by Steptoe LLP · Everything Orexo US, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$150,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Lobbyists on this filing 1

TAYLOR BUSH New on this filing

Previously held: Deputy White House Liaison, U.S. Department of Homeland Security; White House Liaison, U.S. Department of Energy; Special Advisor, U.S. Department of State

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Alcohol and Drug Abuse

Advocacy on xylazine and adultered-opioid overdose solutions and federal funding.

Budget/Appropriations

Advocacy on xylazine and adultered-opioid overdose solutions and federal funding.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.